Pulmonx Corporation
LUNGNASDAQHealthcare● Active
$1.50
+$0.01(+0.67%)
Market Cap$63355800
P/E Ratio—
52W High$3.88
52W Low$1.13
Pulmonx Corporation (LUNG) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · LUNG · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $90.50M | $83.79M | $68.67M | $53.66M | $48.42M |
| Cost of Revenue | $23.36M | $21.79M | $17.92M | $13.80M | $12.79M |
| Gross Profit | $67.14M | $62.00M | $50.75M | $39.87M | $35.63M |
| Gross Margin %(computed) | 74.19% | 74.00% | 73.90% | 74.29% | 73.59% |
| Operating Expenses | |||||
| R&D Expenses | $19.49M | $17.57M | $18.08M | $15.40M | $13.06M |
| G&A Expenses | $0.00M | $94.23M | $89.81M | $0.00M | $0.00M |
| Total Operating Expenses | $120.80M | $119.70M | $112.69M | $98.50M | $82.93M |
| Operating Income | ($53.66M) | ($57.70M) | ($61.94M) | ($58.64M) | ($47.30M) |
| Operating Margin %(computed) | -59.30% | -68.87% | -90.19% | -109.27% | -97.70% |
| Interest Income | $2.65M | $5.06M | $5.57M | $1.53M | $0.40M |
| Interest Expense | $3.15M | $3.51M | $3.23M | $1.07M | $0.83M |
| Income Before Tax | ($53.38M) | ($55.89M) | ($60.27M) | ($58.57M) | ($48.32M) |
| Income Tax Expense | $0.63M | $0.50M | $0.57M | $0.35M | $0.34M |
| Net Income | ($54.00M) | ($56.39M) | ($60.84M) | ($58.92M) | ($48.66M) |
| Net Margin %(computed) | -59.67% | -67.30% | -88.60% | -109.80% | -100.51% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.33 | $-1.44 | $-1.60 | $-1.59 | $-1.35 |
| Wtd Avg Shares | 40.69M | 39.11M | 37.97M | 37.10M | 36.13M |
| EBITDA | ($52.61M) | ($50.79M) | ($55.09M) | ($55.99M) | ($46.62M) |
| EBITDA Margin %(computed) | -58.13% | -60.62% | -80.22% | -104.34% | -96.29% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Pulmonx Corporation data
About Pulmonx Corporation (LUNG) Income Statement
Pulmonx Corporation (LUNG) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, LUNG reported revenue of $0.09B, gross profit of $0.07B (gross margin 74.19%), and net income of ($0.05B) — a net profit margin of -59.67%.
Frequently asked questions
LUNG · 4 questionsPulmonx Corporation (LUNG) reported revenue of $0.09B for 2025, up 8.0% year-over-year.
LUNG revenueLUNG salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09